As used in this subchapter: (1) "Eligible patient" means a person who meets the requirements of eligibility in § 20-15-2104 ; (2) "Investigational drug, biological product, or device" means a drug, biological product, or device that: (A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and (B) Remains currently under investigation in a United States Food and Drug Administration clinical trial; (3) "Physician" means an individual licensed to practice medicine in the State of Arkansas under the Arkansas Medical Practices Act, § 17-95-201 et seq., § 17-95-301 et seq., and § 17-95-401 et seq.; and (4) "Terminal illness" means an incurable and irreversible condition that without the administration of life-sustaining treatment will, in the opinion of the patient's physician, result in death within a relatively short time. Added by Act 2015, No. 374,§ 1, eff. 7/22/2015. As used in this subchapter: (1) "Eligible patient" means a person who meets the requirements of eligibility in § 20-15-2104 ; (2) "Investigational drug, biological product, or device" means a drug, biological product, or device that: (A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and (B) Remains currently under investigation in a United States Food and Drug Administration clinical trial; (3) "Physician" means an individual licensed to practice medicine in the State of Arkansas under the Arkansas Medical Practices Act, § 17-95-201 et seq., § 17-95-301 et seq., and § 17-95-401 et seq.; and (4) "Terminal illness" means an incurable and irreversible condition that without the administration of life-sustaining treatment will, in the opinion of the patient's physician, result in death within a relatively short time. Added by Act 2015, No. 374,§ 1, eff. 7/22/2015. As used in this subchapter: (1) "Eligible patient" means a person who meets the requirements of eligibility in § 20-15-2104 ; (2) "Investigational drug, biological product, or device" means a drug, biological product, or device that: (A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and (B) Remains currently under investigation in a United States Food and Drug Administration clinical trial; (3) "Physician" means an individual licensed to practice medicine in the State of Arkansas under the Arkansas Medical Practices Act, § 17-95-201 et seq., § 17-95-301 et seq., and § 17-95-401 et seq.; and (4) "Terminal illness" means an incurable and irreversible condition that without the administration of life-sustaining treatment will, in the opinion of the patient's physician, result in death within a relatively short time. Added by Act 2015, No. 374,§ 1, eff. 7/22/2015. As used in this subchapter: (1) "Eligible patient" means a person who meets the requirements of eligibility in § 20-15-2104 ; (2) "Investigational drug, biological product, or device" means a drug, biological product, or device that: (A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and (B) Remains currently under investigation in a United States Food and Drug Administration clinical trial; (A) Has successfully completed phase I of clinical trials but has not been approved for general use by the United States Food and Drug Administration; and (B) Remains currently under investigation in a United States Food and Drug Administration clinical trial; (3) "Physician" means an individual licensed to practice medicine in the State of Arkansas under the Arkansas Medical Practices Act, § 17-95-201 et seq., § 17-95-301 et seq., and § 17-95-401 et seq.; and (4) "Terminal illness" means an incurable and irreversible condition that without the administration of life-sustaining treatment will, in the opinion of the patient's physician, result in death within a relatively short time.
‹ Prev All Arkansas sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.